Elevated PSA Levels Explained
What a high PSA means, the many causes beyond cancer, and the current Australian approach — written for patients by health data analysts.
What Is PSA?
Prostate-specific antigen (PSA) is a protein produced by cells of the prostate gland. Its normal function is to liquefy semen. A small amount leaks into the bloodstream, and this is what your blood test measures. PSA is prostate-specific, not cancer-specific — any condition that enlarges, inflames, or disrupts the prostate can raise PSA.
The traditional cutoff of 4.0 µg/L was established in the 1990s, but modern practice uses age-specific ranges and additional metrics (velocity, density, free/total ratio) to improve accuracy. A PSA of 5.0 in a 75-year-old with a large prostate may be entirely benign, while a PSA of 2.5 in a 45-year-old with a family history may warrant closer monitoring.
Age-Specific PSA Ranges
PSA naturally increases with age as the prostate grows. These age-adjusted ranges align with Prostate Cancer Foundation of Australia guidelines.
Men aged 40–49
PSA should be very low in this age group. Levels above 2.0 warrant monitoring even if below 4.0.
Men aged 50–59
The prostate grows with age, causing a natural PSA rise. The traditional 4.0 cutoff misses some cancers in this group.
Men aged 60–69
BPH becomes increasingly common, contributing to higher baseline PSA. Context is essential.
Men aged 70+
Higher levels are more common due to BPH. Screening is generally not recommended over 70 unless life expectancy exceeds 7 years.
Post-prostatectomy
After complete prostate removal, PSA should be undetectable. Any measurable PSA suggests residual or recurrent disease.
Beyond the Number — Advanced PSA Metrics
A single PSA number tells only part of the story. These additional metrics help refine the interpretation.
PSA velocity
The rate of PSA change over time, calculated from at least 3 measurements over 18–24 months.
A rise of more than 0.75 µg/L per year is suspicious, even if the absolute PSA is within the normal range. SmarterBlood tracks this automatically.
PSA doubling time
How long it takes for PSA to double. Most useful after treatment for monitoring recurrence.
Doubling time less than 12 months after treatment suggests aggressive disease. Longer doubling times are more favourable.
Free/total PSA ratio
PSA exists in free and protein-bound forms. Cancer tends to produce more bound PSA.
Free PSA ratio above 25% favours BPH. Below 10% is more concerning for cancer. Used to refine risk when total PSA is 4–10 µg/L.
PSA density
PSA divided by prostate volume (measured on ultrasound or MRI).
Density above 0.15 µg/L/mL suggests the PSA is disproportionate to prostate size, raising cancer suspicion.
Common Causes of Elevated PSA
Cancer is only one of many reasons PSA can be elevated. Most causes are benign.
Benign prostatic hyperplasia (BPH)
The most common cause of elevated PSA in men over 50. The prostate enlarges naturally with age, and more prostate tissue produces more PSA. BPH affects about 50% of men by age 60 and 90% by age 85.
Prostatitis
Inflammation or infection of the prostate can dramatically raise PSA, sometimes to 20–50+ µg/L. PSA typically normalises within 6–8 weeks after treatment. Always recheck PSA after prostatitis resolves.
Recent ejaculation
Ejaculation within 24–48 hours before a blood test can raise PSA by 0.5–1.0 µg/L. Most guidelines recommend abstaining for 48 hours before a PSA test.
Vigorous cycling
Prolonged cycling puts pressure on the prostate and can temporarily raise PSA. Studies show increases of 0.5–2.0 µg/L after long rides. Avoid cycling for 48 hours before a PSA test.
Urinary tract infection
UTIs can cause inflammation that spreads to the prostate, raising PSA. Any mildly elevated PSA with urinary symptoms should be rechecked after the infection is treated.
Digital rectal examination (DRE)
A DRE performed before the blood draw can mildly elevate PSA. The effect is small (typically <0.5 µg/L). Best practice is to draw blood before the DRE.
Prostate cancer
Cancer cells produce more PSA per gram of tissue than normal cells. However, PSA is NOT cancer-specific — it is prostate-specific. Most men with PSA 4–10 do NOT have cancer (only about 25% will have cancer on biopsy).
5-alpha reductase inhibitors
Finasteride and dutasteride reduce PSA by approximately 50% after 6 months. Your GP must double the measured PSA to get the true value. Failure to account for this can mask a rising PSA.
What Your GP Will Do Next
An elevated PSA triggers a step-by-step investigation. Modern Australian practice emphasises MRI before biopsy.
1. Rule out confounders
Your GP will ask about recent ejaculation, cycling, UTI symptoms, prostatitis history, and medications. If any could explain the elevation, a repeat test after eliminating the confounder is the logical first step.
2. Repeat the PSA test
A single elevated PSA is NOT diagnostic. Your GP will repeat the test in 4–6 weeks under controlled conditions: no ejaculation for 48 hours, no cycling, no UTI, well hydrated.
3. Free/total PSA ratio
If total PSA is in the 4–10 µg/L grey zone, free PSA helps refine the risk. A ratio above 25% is reassuring (favours BPH). Below 10% increases concern.
4. Multiparametric MRI (mpMRI)
Australian guidelines now recommend MRI BEFORE biopsy. MRI scores lesions on the PI-RADS scale (1–5). PI-RADS 1–2 is reassuring. PI-RADS 4–5 is suspicious. Medicare covers mpMRI for PSA investigation.
5. Prostate biopsy
If MRI shows a suspicious lesion (PI-RADS 3–5), a targeted transperineal biopsy is performed. This is now the standard approach in Australia, replacing the older transrectal route due to lower infection risk.
6. Urologist referral
Your GP will refer to a urologist if PSA is persistently elevated, rising rapidly, or if MRI is abnormal. In Australia, urologists work through both public hospital clinics (Medicare bulk-billed) and private rooms.
Frequently Asked Questions
Does a high PSA mean I have prostate cancer?
No. Most men with mildly elevated PSA do NOT have cancer. In the 4–10 µg/L range, only about 25% of biopsies find cancer. BPH, prostatitis, recent ejaculation, and cycling are all common benign causes. PSA is prostate-specific, not cancer-specific.
Should I be screened for prostate cancer?
This is a personal decision best made with your GP. Australian guidelines recommend informed decision-making rather than routine screening. Benefits include earlier detection. Risks include overdiagnosis of slow-growing cancers. Discuss your risk factors with your GP.
My father had prostate cancer. Does that increase my risk?
Yes. A first-degree relative with prostate cancer approximately doubles your risk. Men with a strong family history are advised to discuss PSA testing from age 40, rather than the usual age 50. Genetic testing (BRCA2) may be considered in high-risk families.
I take finasteride for hair loss. How does that affect my PSA?
Finasteride reduces PSA by approximately 50% after 6 months. Your GP must DOUBLE your measured PSA to estimate the true level. Always tell your GP about finasteride use.
How often should I have my PSA checked?
For men who choose screening: baseline at age 50 (or 40–45 with family history). If PSA is below 1.0 at age 60, less frequent testing (every 2–4 years) is reasonable. If above 3.0, annual testing is typical. Over 70, screening is generally not recommended.
What is a "grey zone" PSA result?
The grey zone refers to PSA 4.0–10.0 µg/L. About 75% of men in this range do NOT have cancer on biopsy — but 25% do. Free/total PSA ratio, PSA density, PSA velocity, and MRI findings help refine the risk.
Related Reading
Track Your PSA Over Time
Upload your blood test results and SmarterBlood will chart your PSA velocity and trends automatically — the single most important factor in PSA interpretation.
This information is based on guidelines from the Prostate Cancer Foundation of Australia (PCFA), Cancer Council Australia, the RACGP, and the Urological Society of Australia and New Zealand (USANZ). SmarterBlood provides educational information only and is not a substitute for professional medical advice.